Adial Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary

Adial Pharmaceuticals

14/11/2024 14:16

* Adial Pharmaceuticals Inc  ADIL.OQ  reported a quarterly
adjusted loss of 38 cents​​ per share for the quarter ended
September 30, higher than the same quarter last year, when the
company reported EPS of $-1.18.  The mean expectation of
three analysts for the quarter was for a loss of 44 cents per
share. Wall Street expected results to range from -50 cents
to -32 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Adial Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 38 cents​.
    * The company reported a quarterly loss of $2.19 million.
    * Adial Pharmaceuticals Inc shares had fallen by 0.8% this
quarter and lost 46.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 6.5%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Adial
Pharmaceuticals Inc is $7.50 
This summary was machine generated from LSEG data November 14 at
02:16 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.44          -0.38          Beat
 Jun. 30 2024      -0.53          -0.59          Missed
 Mar. 31 2024      -0.33          -0.62          Missed
 Dec. 31 2023      -0.76          -1.35          Missed